跳至主要内容
临床试验/EUCTR2016-004358-14-IT
EUCTR2016-004358-14-IT进行中(未招募)1 期

Bromfenac 0.09% versus dexamethasone 0.1% ophthalmic solutions to reduce inflammation after cataract surgery: the BVD Study. - BVD Study

AZIENDA OSPEDALIERA ARCISPEDALE SANTA MARIA NUOVA/IRCCS DI REGGIO EMILIA0 个研究点目标入组 76 人开始时间: 2021年6月8日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
76

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Patients that underwent uneventful cataract surgery;
  • -Patients aged >60 year old (for women, the menopausal state is assumed);
  • -A signed informed consent for this study protocol is mandatory.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 6
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 70

排除标准

  • Patients with history of ocular inflammation or trauma, previous intraocular surgery, corneal haze, pseudoexfoliatio lentis, retinal vascular disease, diabetic retinopathy, variation of the foveal profile at OCT (including macular edema and epiretinal membrane), moderate to severe age related macular degeneration.
  • Patients could not be enrolled in another clinical study concurrently.

研究者

发起方
AZIENDA OSPEDALIERA ARCISPEDALE SANTA MARIA NUOVA/IRCCS DI REGGIO EMILIA

相似试验

To compare the efficacy of bromfenac ophthalmic... | 临床试验